Key facts
- This page summarizes Clay B. Siegall's Form 4 filing for Seagen Inc..
- 12 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 11 Jan 2022, 18:14.
Clay B. Siegall - 07 Jan 2022 Form 4 Insider Report for Seagen Inc.
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 07 Jan 2022
- Net transaction value
- -$2,021,895
- SEC form
- 4
- Accepted by SEC
- 11 Jan 2022, 18:14:52 UTC
- Prior SEC filing
- 22 Dec 2021
- Next SEC filing
- 09 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Jennifer Prosba For: Clay B. Siegall
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Clay B. Siegall filed Form 4 for Seagen Inc. on 11 Jan 2022.
Change
- Previous filing in this sequence was filed on 22 Dec 2021.
- Current net transaction value: -$2,021,895.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SGEN
transaction
Common Stock
Options Exercise
- Transaction value
- $28,710
- Shares
- +1,100
- Change %
- +0.16%
- Price
- $26.10
- Shares after
- 669,045
- Date
- 07 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
SGEN
transaction
Common Stock
Sale
- Transaction value
- $161,876
- Shares
- -1,100
- Change %
- -0.16%
- Price
- $147.16
- Shares after
- 667,945
- Date
- 07 Jan 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
SGEN
transaction
Common Stock
Options Exercise
- Transaction value
- $84,068
- Shares
- +3,221
- Change %
- +0.48%
- Price
- $26.10
- Shares after
- 671,166
- Date
- 07 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
SGEN
transaction
Common Stock
Sale
- Transaction value
- $469,751
- Shares
- -3,221
- Change %
- -0.48%
- Price
- $145.84
- Shares after
- 667,945
- Date
- 07 Jan 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F4
SGEN
transaction
Common Stock
Options Exercise
- Transaction value
- $119,016
- Shares
- +4,560
- Change %
- +0.68%
- Price
- $26.10
- Shares after
- 672,505
- Date
- 07 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
SGEN
transaction
Common Stock
Sale
- Transaction value
- $660,379
- Shares
- -4,560
- Change %
- -0.68%
- Price
- $144.82
- Shares after
- 667,945
- Date
- 07 Jan 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F5
SGEN
transaction
Common Stock
Options Exercise
- Transaction value
- $213,054
- Shares
- +8,163
- Change %
- +1.2%
- Price
- $26.10
- Shares after
- 676,108
- Date
- 07 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
SGEN
transaction
Common Stock
Sale
- Transaction value
- $1,174,737
- Shares
- -8,163
- Change %
- -1.2%
- Price
- $143.91
- Shares after
- 667,945
- Date
- 07 Jan 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F6
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SGEN
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,100
- Change %
- -0.81%
- Price
- $0.000000
- Shares after
- 135,245
- Date
- 07 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,100
- Exercise price
- $26.10
- Footnotes
- F7
SGEN
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,221
- Change %
- -2.4%
- Price
- $0.000000
- Shares after
- 132,024
- Date
- 07 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,221
- Exercise price
- $26.10
- Footnotes
- F7
SGEN
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -4,560
- Change %
- -3.5%
- Price
- $0.000000
- Shares after
- 127,464
- Date
- 07 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,560
- Exercise price
- $26.10
- Footnotes
- F7
SGEN
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -8,163
- Change %
- -6.4%
- Price
- $0.000000
- Shares after
- 119,301
- Date
- 07 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,163
- Exercise price
- $26.10
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Footnote F2
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Footnote F3
Reflects sales of common stock executed in multiple transactions at prices ranging from $146.71 to $147.68. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F4
Reflects sales of common stock executed in multiple transactions at prices ranging from $145.42 to $146.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F5
Reflects sales of common stock executed in multiple transactions at prices ranging from $144.41 to $145.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F6
Reflects sales of common stock executed in multiple transactions at prices ranging from $143.41 to $144.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Footnote F7
Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16.